We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.46B
AUM Growth
+$49M
Cap. Flow
-$115M
Cap. Flow %
-7.85%
Top 10 Hldgs %
30.33%
Holding
150
New
19
Increased
27
Reduced
60
Closed
16

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$17M
2
ACM icon
Aecom
ACM
+$15.5M
3
MET icon
MetLife
MET
+$15.5M
4
SPGI icon
S&P Global
SPGI
+$14.5M
5
UNP icon
Union Pacific
UNP
+$13.6M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$20.9M
2
GIS icon
General Mills
GIS
+$20.9M
3
UNH icon
UnitedHealth
UNH
+$18.2M
4
CB icon
Chubb
CB
+$17.9M
5
ABBV icon
AbbVie
ABBV
+$17.3M

Sector Composition

Rank Sector Weight
1 Financials 13.92%
2 Technology 11.39%
3 Industrials 11.14%
4 Energy 10.8%
5 Healthcare 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$324B
$17.2M 1.17%
166,850
-29,100
-15% -$3.14M
DELL icon
27
Dell
DELL
$283B
$16.7M 1.14%
242,200
-163,800
-40% -$9.76M
GOOGL icon
28
Alphabet (Google) Class A
GOOGL
$3.91T
$16.3M 1.11%
124,700
-3,900
-3% -$505K
AMAT icon
29
Applied Materials
AMAT
$426B
$16.2M 1.1%
116,810
-3,000
-3% -$430K
LLY icon
30
Eli Lilly
LLY
$1.07T
$16.1M 1.1%
29,920
-800
-3% -$412K
MPC icon
31
Marathon Petroleum
MPC
$90.3B
$16M 1.09%
105,700
+31,500
+42% +$4.39M
MET icon
32
MetLife
MET
$61B
$15.6M 1.07%
+248,300
New +$15.5M
ORCL icon
33
Oracle
ORCL
$331B
$15.5M 1.06%
146,290
+1,530
+1% +$177K
ETN icon
34
Eaton
ETN
$157B
$15.5M 1.06%
72,640
-67,760
-48% -$14.6M
EXC icon
35
Exelon
EXC
$48.6B
$15.2M 1.04%
402,310
-8,300
-2% -$338K
DD icon
36
DuPont de Nemours
DD
$18.6B
$15.1M 1.03%
161,325
-3,983
-2% -$374K
PEP icon
37
PepsiCo
PEP
$186B
$14.9M 1.02%
88,000
+7,300
+9% +$1.33M
PG icon
38
Procter & Gamble
PG
$343B
$14.9M 1.02%
101,980
-2,400
-2% -$367K
DHI icon
39
D.R. Horton
DHI
$41B
$14.4M 0.98%
134,020
+66,120
+97% +$7.92M
LIN icon
40
Linde
LIN
$237B
$14.3M 0.98%
38,500
+21,000
+120% +$7.99M
AMZN icon
41
Amazon
AMZN
$2.5T
$14.1M 0.97%
111,170
+89,500
+413% +$12M
TXN icon
42
Texas Instruments
TXN
$255B
$13.9M 0.95%
87,380
-1,900
-2% -$324K
SLB icon
43
SLB Ltd
SLB
$77.8B
$13.7M 0.93%
234,700
-5,900
-2% -$342K
IBM icon
44
IBM
IBM
$202B
$13.6M 0.93%
97,270
+5,100
+6% +$726K
SPGI icon
45
S&P Global
SPGI
$126B
$13.5M 0.92%
+36,890
New +$14.5M
CRM icon
46
Salesforce
CRM
$134B
$13.3M 0.91%
65,600
+29,800
+83% +$6.44M
GPK icon
47
Graphic Packaging
GPK
$3.26B
$13.3M 0.91%
597,040
+310,940
+109% +$7.13M
CTAS icon
48
Cintas
CTAS
$82.4B
$13M 0.89%
+108,400
New +$13.5M
CB icon
49
Chubb
CB
$140B
$13M 0.89%
62,270
-88,400
-59% -$17.9M
ROST icon
50
Ross Stores
ROST
$76.6B
$12.9M 0.88%
+113,800
New +$13.1M
1
2
3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2023 Portfolio in Review

As of Q3 2023, Payden & Rygel held 150 positions worth $1.46B, up 3.5% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Payden & Rygel withdrew a net $115M in Q3 2023, closing 16 positions and reducing 60 holdings. Its most notable exit was RTX Corp, an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Payden & Rygel opened a new position in MetLife worth $15.6M.

  • Payden & Rygel's largest Q3 2023 buy was MetLife: 248,300 shares worth $15.6M.
  • Payden & Rygel added most to ConocoPhillips in Q3 2023, an estimated $17M increase.
  • Payden & Rygel's biggest Q3 2023 reduction was UnitedHealth, cutting an estimated $18.2M.
  • Payden & Rygel fully exited RTX Corp in Q3 2023, selling an estimated $20.9M.
  • Payden & Rygel's ten largest holdings make up 30% of its $1.46B portfolio in Q3 2023.
  • Payden & Rygel opened 19 new positions and closed 16 in Q3 2023.
  • Payden & Rygel's portfolio value rose 3.5% quarter-over-quarter to $1.46B.

Based on Payden & Rygel's 13F filing for Q3 2023, filed 7 Oct 2024.